Table 4 Reporting of cystectomy specimens
From: Staging and reporting of urothelial carcinoma of the urinary bladder
Gross findings |
Fresh or fixed specimen |
Nature of the specimen: partial cystectomy, radical cystectomy, cystoprostatectomy, pelvic exenteration |
Three-dimensional measurements of recognizable anatomic structures, and of tumors or other recognizable lesions |
Site of involvement |
Growth pattern (papillary, ulcerated, solid, nodular, infiltrative) |
Gross assessment of invasion (into lamina propria or muscularis propria) |
Gross extravesical fat extension |
Gross invasion into adjacent organs, such as prostate, ureter, urethra, uterus, vagina, pelvic, and abdominal wall |
Gross assessment of margin status |
Lymph nodes |
Location and the number of lymph nodes sampled |
Report if the lymph nodes are bisected or completely embedded |
Report if the lymph nodes are grossly involved by cancer |
Microscopic findings |
Anatomic location of the tumor |
Histological diagnosis |
Tumor size and multifocality |
Histological grade |
Pattern of invasion (nodular, trabecular, or infiltrative) |
Extent of invasion (pathological staging) |
No invasion (pTa or pTis) |
Invasion into the lamina propria (pT1) |
Invasion into inner or outer half of muscularis propria (pT2) |
Invasion into perivesical soft tissue (pT3) |
Tumor arising in a diverticulum (specify whether detrusor muscle is present) |
Surgical margins |
Ureteral margin |
Urethral margins |
Perivesical soft tissue margin |
Pelvic soft tissue margin (or pelvic exenteration specimens) |
The presence or absence of lymphovascular invasion |
Other intraepithelial abnormalities |
The presence or absence of dysplasia and carcinoma in situ in adjacent mucosa |
Location and multifocality |
Other findings such as intestinal metaplasia, therapeutic treatment effects etc. |
Extent of tumor invasion into adjacent organs |
Prostate |
a. Involvement of the prostatic urethra with or without stromal invasion |
b. Involvement of prostatic ducts/acini without stromal invasion |
c. Prostatic stromal invasion |
d. Direct extension into the prostate from carcinoma through the bladder neck |
e. Direct extravesical extension into the prostatic parenchyma |
f. Seminal vesicle invasion through intraprostatic epithelium or by direct perivesical extension |
Ureter and urethra |
a. Report any dysplastic/neoplastic change of the mucosa, including pagetoid spread of carcinoma in situ |
b. Report invasion into adjacent lamina propria or muscularis propria |
Seminal vesicles |
Report spread of carcinoma in these organs either through epithelium or by direct extension of an infiltrative carcinoma |
Vagina/uterus |
Report direct extension or metastases to either organ |
Rectum, pelvic and abdominal wall |
Report direct extension or metastases |
Lymph node status |
Report the number of lymph nodes sampled |
Report the presence or absence of metastases |
If metastases are present, state the followings in the report |
The number of positive nodes |
The overall size the largest positive (<2, 2.1–5, >5 cm) (for N staging) |
The diameter of the largest metastasis |
The presence or absence of extranodal extension |
Final pathological staging (using the most current TNM staging) |
Results of ancillary studies (if performed) |
Correlation with frozen section diagnosis (if performed) |